Clinical Trials Directory

Trials / Conditions / Transfusion-dependent Thalassemia

Transfusion-dependent Thalassemia

7 registered clinical trials studyying Transfusion-dependent Thalassemia — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingEvaluation of Recombinant Humanized Anti-CD25 Monoclonal Antibody for Preventing Graft-versus-host Disease Aft
NCT06657391
Rongrong LiuPhase 2
UnknownEfficacy of Combination of Hdroxyurea and Thalidomide Over Either Hydroxyurea or Thalidomide Alone in the Trea
NCT06299670
Bangabandhu Sheikh Mujib Medical University, Dhaka, BangladeshPhase 4
RecruitingA Study Evaluating the Safety and Efficacy of the GMCN-508A Drug Product in Transfusion-dependent α-Thalassemi
NCT05757245
First Affiliated Hospital of Guangxi Medical UniversityPhase 1
CompletedSafety & Efficacy of Thalidomide in Children With Transfusion Dependent Thalassemia
NCT06098014
Bangabandhu Sheikh Mujib Medical University, Dhaka, BangladeshPhase 1
TerminatedEfficacy and Safety of RBCs Derived From Mirasol-treated Whole Blood in Patients Requiring Chronic Transfusion
NCT03329404
Terumo BCTbioN/A
CompletedOpen-label, Multicenter Study Assessing Preference for Deferasirox Film-coated Tablet Compared to Dispersible
NCT02993224
Novartis PharmaceuticalsPhase 2
CompletedEndocrine Function During Deferasirox Therapy
NCT04515680
University of Campania Luigi Vanvitelli—